Labetuzumab govitecan (ADC)
Labetuzumab govitecan is an ADC consisting of a CEACAM5-directed antibody and SN38 used for the study of various cancers including colorectal cancer.
Product Specifications
Product Name Alternative
IMMU130, hMN-14-SN-38
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Form
Liquid
Notes
For research use only. Not suitable for clinical or therapeutic use.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6499469-01 0.2 mL
Siglec 9, CT (Sialic Acid-binding Ig-like Lectin 9, Siglec 9, Protein FOAP-9, UNQ668/PRO1302) (APC)
Ask
View Details 
MBS6499469-02 5x 0.2 mL
Siglec 9, CT (Sialic Acid-binding Ig-like Lectin 9, Siglec 9, Protein FOAP-9, UNQ668/PRO1302) (APC)
Ask
View Details 